Memorial Sloan - Kettering Cancer Center
6
52M
5
0.04
0.17
1
- Areas of investment
Summary
Memorial Sloan - Kettering Cancer Center is the famous Corporate Investor, which was founded in 1884. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the New York.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2018.
The typical case for the fund is to invest in rounds with more than 10 participants. Despite the Memorial Sloan - Kettering Cancer Center, startups are often financed by The Column Group, OrbiMed, Med-Metrix. The meaningful sponsors for the fund in investment in the same round are The Column Group, Taiho Ventures, OrbiMed. In the next rounds fund is usually obtained by Topspin Partners, The Column Group, Taiho Ventures.
The current fund was established by Charlotte Augusta Gibbes, John Jacob Astor III.
Among the most popular portfolio startups of the fund, we may highlight Cota Healthcare. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Information Technology, Information Services.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.04
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (5)
- Health Care (5)
- Therapeutics (3)
- Life Science (3)
- Pharmaceutical (2) Show 2 more
- Investments by region
-
- United States (6)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Flare Therapeutics | 22 Mar 2023 | Biotechnology, Health Care, Life Science | Early Stage Venture | 123M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.